
News|Articles|August 21, 2006
New product newswire: August 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol. The new inhaler is indicated for long-term maintenance treatment of asthma in patients 12 years of age and older.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
GoodRx Offers Wegovy Weight-Loss Pill at Under $150 a Month
2
Bepirovirsen Meets Primary End Point for Functional Cure Rate of Hepatitis B
3
The PBM Putting Pharmacists at the Center of Formulary Design
4
HHS Limits Vaccine Recommendations for Childhood Schedules
5










































































































































































































